ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 55 filers reported holding ITEOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,754,435 | +69165.2% | 1,804,058 | -16.2% | 1.05% | -20.5% |
| Q2 2023 | $28,520 | -2.7% | 2,154,058 | 0.0% | 1.32% | -8.1% |
| Q1 2023 | $29,317 | -99.9% | 2,154,058 | 0.0% | 1.44% | -35.1% |
| Q4 2022 | $42,068,752 | +2.5% | 2,154,058 | 0.0% | 2.22% | -3.9% |
| Q3 2022 | $41,035,000 | -7.5% | 2,154,058 | 0.0% | 2.31% | -17.9% |
| Q2 2022 | $44,374,000 | -56.8% | 2,154,058 | -32.5% | 2.81% | -46.8% |
| Q1 2022 | $102,720,000 | -49.2% | 3,192,058 | -26.5% | 5.28% | -32.8% |
| Q4 2021 | $202,304,000 | +72.4% | 4,345,016 | 0.0% | 7.86% | +91.8% |
| Q3 2021 | $117,315,000 | +5.3% | 4,345,016 | 0.0% | 4.10% | +4.2% |
| Q2 2021 | $111,450,000 | -25.0% | 4,345,016 | 0.0% | 3.93% | -21.9% |
| Q1 2021 | $148,513,000 | +1.1% | 4,345,016 | 0.0% | 5.04% | +6.6% |
| Q4 2020 | $146,948,000 | +37.1% | 4,345,016 | 0.0% | 4.72% | +27.5% |
| Q3 2020 | $107,192,000 | – | 4,345,016 | – | 3.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |